Furthermore, Ge et al. found that EPO/EPOR signaling activates the hepatic AKT pathway by increasing PPARγ expression and activity, which improvements in hepatic insulin resistance (Ge et al. 2015). This evidence concerns the gene EPO and Insulin resistance.